Dupixent® (dupilumab): Now Approved for an Expanded Indication

Registration: 7 p.m.
Session: 7-8:30 p.m., Saturday, July 27 (Food and beverage is provided.)

Facility: New York Hilton Midtown
Room: Grand Ballroom West

Sponsor: Regeneron and Sanofi Genzyme

Exhibit Hall Booth Number: 728

Program Overview:  DUPIXENT is approved by the FDA. Come learn about clinical efficacy, safety information, MOA, dosing and administration, and how DUPIXENT may help your patients. Pre-registration is provided for this INC Program. Register by emailing dermatologyevents@significantmeetings.com or calling 973-500-2068.